View source for Definition:Utilization review organization (URO)

🏥 '''Utilization review organization (URO)''' is an entity — either independent or affiliated with a [[Definition:Health insurance | health insurer]] — that evaluates the medical necessity, appropriateness, and efficiency of healthcare services before, during, or after they are delivered to policyholders. Within insurance operations, UROs serve as a critical cost-containment mechanism, ensuring that [[Definition:Claim | claims]] payments correspond to treatments that are clinically justified under the terms of a given [[Definition:Insurance policy | policy]]. Many states regulate UROs through specific licensing requirements and mandate that their clinical determinations be made or supervised by licensed physicians.

🔍 A URO typically conducts three types of review. [[Definition:Prior authorization | Prospective review]] (prior authorization) assesses whether a proposed treatment meets coverage criteria before care begins. Concurrent review monitors ongoing inpatient stays or treatment courses to confirm continued medical necessity. Retrospective review examines services already rendered, often as part of [[Definition:Claims adjudication | claims adjudication]], to identify overutilization or billing anomalies. Each review type feeds data back to the insurer's [[Definition:Underwriting | underwriting]] and [[Definition:Actuarial science | actuarial]] teams, refining [[Definition:Utilization rate | utilization rate]] assumptions and strengthening future [[Definition:Ratemaking | ratemaking]] accuracy. UROs increasingly rely on [[Definition:Clinical decision support | clinical decision-support]] algorithms and [[Definition:Artificial intelligence (AI) | AI]]-driven triage tools to handle high volumes while maintaining consistency.

⚖️ The work of a URO sits at the intersection of clinical judgment and insurance economics, which makes it a frequent target of regulatory scrutiny and consumer advocacy. Denied authorizations can trigger [[Definition:Appeals process | appeals processes]] governed by state insurance law and, for employer-sponsored plans, federal [[Definition:Employee Retirement Income Security Act (ERISA) | ERISA]] rules. For carriers and [[Definition:Managed care organization (MCO) | managed care organizations]], partnering with a well-run URO translates directly into lower [[Definition:Medical loss ratio (MLR) | medical loss ratios]] without sacrificing care quality — a balance that regulators and [[Definition:National Association of Insurance Commissioners (NAIC) | NAIC]] model acts increasingly require UROs to demonstrate through transparent reporting and external review mechanisms.

'''Related concepts:'''
{{Div col|colwidth=20em}}
* [[Definition:Utilization review]]
* [[Definition:Prior authorization]]
* [[Definition:Managed care organization (MCO)]]
* [[Definition:Medical necessity]]
* [[Definition:Claims adjudication]]
* [[Definition:Medical loss ratio (MLR)]]
{{Div col end}}